Africa CDC in talks with Pfizer about a COVID treatment pill


The director of the African Centers for Disease Control says the organization is speaking with Pfizer about bringing its COVID-19 treatment pill to the continent, which has just exceeded 10 million cases

January 13, 2022, 10:58 a.m.

Read for 2 minutes

DAKAR, Senegal_ – The director of the African Centers for Disease Control said the organization is speaking with Pfizer about bringing its COVID-19 treatment pill to the continent, which has just exceeded 10 million cases.

The discussions come when Dr. John Nkengasong urges the government and citizens not to forego vaccinations and preventive measures as waves of increasing infections with the Omicron variant hit different countries.

“We work hand in hand. … We are in close talks with Pfizer to see what can be done to make the drugs available on the continent, “Nkengasong said at a press conference on Thursday.

At least 39 countries have reported the new variant, and the average increase in cases in Africa is about 11 percent, he said.

He pointed out that vaccination rates are still not high enough, and said governments are struggling because so many people are only vaccinated at peak times, leading to many hospitalizations and pressure on systems that could be avoided.

“My advice to the people of the continent is to get vaccinated,” he said. “When the population is unwilling to get the vaccines that governments have worked so hard to bring to the continent, I see why countries have no choice but to impose vaccine mandates.”

The continent has received more than 660 million doses of vaccine, of which only about 340 million doses have been given.

Read the original article here

Denial of responsibility! Verve Times is an automatic aggregator of all media in the world. The hyperlink to the primary source is given in each piece of content. All trademarks belong to their rightful owners, all materials to their authors. If you are the content owner and do not want us to publish your materials, please contact us by email – [email protected]. The content will be deleted within 24 hours.

Comments are closed.